SARS-CoV-2 risk taxation model and validation based on large scale Dutch test-events

Bas Kolen, Laurens Znidarsic, Andreas Voss, Simon Donders, Iris Kamphorst, Maarten van Rijn, Dimitri Bonthuis, Merit Cloquet, Maarten Schram, Rutger Scharloo, Tim Boersma, Tim Stobernack, Pieter van Gelder
doi: https://doi.org/10.1101/2022.01.10.21268254

Article usage

Article usage: January 2022 to January 2025

AbstractFullPdf
Jan 202271912138
Feb 2022265557
Mar 202217293
Apr 2022284019
May 2022142111
Jun 2022132023
Jul 20225922
Aug 20224727
Sep 202250411
Oct 202255112
Nov 20222306
Dec 20222013
Jan 20231314
Feb 20232629
Mar 20231602
Apr 20231912
May 2023815
Jun 2023743
Jul 2023311
Aug 202313115
Sep 2023852
Oct 2023912
Nov 20231314
Dec 20231264
Jan 2024811
Feb 20241212
Mar 20241164
Apr 2024910
May 2024977
Jun 2024523
Jul 20245113
Aug 202410110
Sep 20242078
Oct 2024754
Nov 20246114
Dec 20248210
Jan 20255211
Back to top
Posted January 10, 2022.
Download PDF
Data/Code
Email
SARS-CoV-2 risk taxation model and validation based on large scale Dutch test-events
Bas Kolen, Laurens Znidarsic, Andreas Voss, Simon Donders, Iris Kamphorst, Maarten van Rijn, Dimitri Bonthuis, Merit Cloquet, Maarten Schram, Rutger Scharloo, Tim Boersma, Tim Stobernack, Pieter van Gelder
medRxiv 2022.01.10.21268254; doi: https://doi.org/10.1101/2022.01.10.21268254
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area